UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epigenetics as a Therapeutic Target in Breast Cancer

Journal of mammary gland biology and neoplasia, 2012-12, Vol.17 (3-4), p.191-204

2012

Volltextzugriff (PDF)

Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer

The New England journal of medicine, 2014-07, Vol.371 (2), p.107-118

2014

Volltextzugriff (PDF)

CYP2D6 and UGT2B7 Genotype and Risk of Recurrence in Tamoxifen-Treated Breast Cancer Patients

JNCI : Journal of the National Cancer Institute, 2012-03, Vol.104 (6), p.452-460

2012

Volltextzugriff (PDF)

Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast Cancer

Journal of clinical oncology, 2012-03, Vol.30 (9), p.936-942

2012

Volltextzugriff (PDF)

Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management

Breast cancer research : BCR, 2011-03, Vol.13 (2), p.205-205, Article 205

2011

Volltextzugriff (PDF)

Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study

Clinical cancer research, 2017-06, Vol.23 (11), p.2691-2701

2017

Volltextzugriff (PDF)

American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer

Journal of clinical oncology, 2010-08, Vol.28 (23), p.3784-3796

2010

Volltextzugriff (PDF)

Effect of delays in initiation of adjuvant endocrine therapy on survival among women with breast cancer

Breast cancer research and treatment, 2020-12, Vol.184 (3), p.965-975

2020

Volltextzugriff (PDF)

Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers

Oncotarget, 2014-02, Vol.5 (3), p.587-598

2014

Volltextzugriff (PDF)

Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood

Clinical cancer research, 2012-06, Vol.18 (12), p.3462-3469

2012

Volltextzugriff (PDF)

Randomized Trial of a Hypnosis Intervention for Treatment of Hot Flashes Among Breast Cancer Survivors

Journal of clinical oncology, 2008-11, Vol.26 (31), p.5022-5026

2008

Volltextzugriff (PDF)

Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial

Journal of clinical oncology, 2013-04, Vol.31 (11), p.1398-1404

2013

Volltextzugriff (PDF)

Concurrent chemotherapy with partial breast irradiation in triple negative breast cancer patients may improve disease control compared with sequential therapy

Frontiers in oncology, 2023-07, Vol.13, p.1146754-1146754

2023

Volltextzugriff (PDF)

Digital Pathology Analysis Quantifies Spatial Heterogeneity of CD3, CD4, CD8, CD20, and FoxP3 Immune Markers in Triple-Negative Breast Cancer

Frontiers in physiology, 2020-10, Vol.11, p.583333-583333

2020

Volltextzugriff (PDF)

The effect of 1-day multidisciplinary clinic on breast cancer treatment

Breast cancer research and treatment, 2020-08, Vol.182 (3), p.623-629

2020

Volltextzugriff (PDF)

Clinico-pathologic features, treatment and outcomes of breast cancer during pregnancy or the post-partum period

Breast cancer research and treatment, 2020-04, Vol.180 (3), p.695-706

2020

Volltextzugriff (PDF)

The Impact of Radiotherapy Delay in Breast Conservation Patients Not Receiving Chemotherapy and the Rationale for Dichotomizing the Radiation Oncology Time-Dependent Standard into Two Quality Measures

Annals of surgical oncology, 2022, Vol.29 (1), p.469-481

2022

Volltextzugriff (PDF)

Timed Sequential Treatment With Cyclophosphamide, Doxorubicin, and an Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor–Secreting Breast Tumor Vaccine: A Chemotherapy Dose-Ranging Factorial Study of Safety and Immune Activation

Journal of clinical oncology, 2009-12, Vol.27 (35), p.5911-5918

2009

Volltextzugriff (PDF)

Novel Biomarkers in the Continuum of Breast Cancer

Stearns, Vered

1st ed. 2016, 2016

Volltextzugriff (PDF)

Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update

Journal of clinical oncology, 2006-04, Vol.24 (12), p.1940-1949

2006

Volltextzugriff (PDF)

High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer

Breast cancer research and treatment, 2020-01, Vol.179 (1), p.25-35

2020

Volltextzugriff (PDF)

Exploring the links of skeletal muscle mitochondrial oxidative capacity, physical functionality, and mental well-being of cancer survivors

Scientific reports, 2024-02, Vol.14 (1), p.2669-12, Article 2669

2024

Volltextzugriff (PDF)

ASO Visual Abstract: The Impact of Radiotherapy Delay in Breast-Conservation Patients Not Receiving Chemotherapy and the Rationale for Dichotomizing the Radiation Oncology Time-Dependent Standard into Two Quality Measures

Annals of surgical oncology, 2021-12, Vol.28 (Suppl 3), p.572-573

2021

Volltextzugriff (PDF)

Reply to H. Brauch et al

Journal of clinical oncology, 2019-08, Vol.37 (22), p.1986-1986

Stearns, Vered

2019

Volltextzugriff (PDF)

1 – 25 von 427

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(406)
Mit Volltextzugriff
(364)

Publikationsform

Artikel
(408)
Buchkapitel
(17)
Bücher
(1)
Berichte
(1)

Sprache

Englisch
(426)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Epigenetics as a Therapeutic Target in Breast Cancer

Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer

CYP2D6 and UGT2B7 Genotype and Risk of Recurrence in Tamoxifen-Treated Breast Cancer Patients

Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast Cancer

Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management

Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study

American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer

Effect of delays in initiation of adjuvant endocrine therapy on survival among women with breast cancer

Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor Cells

Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers

Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood

Randomized Trial of a Hypnosis Intervention for Treatment of Hot Flashes Among Breast Cancer Survivors

Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial

Concurrent chemotherapy with partial breast irradiation in triple negative breast cancer patients may improve disease control compared with sequential therapy

Digital Pathology Analysis Quantifies Spatial Heterogeneity of CD3, CD4, CD8, CD20, and FoxP3 Immune Markers in Triple-Negative Breast Cancer

The effect of 1-day multidisciplinary clinic on breast cancer treatment

Clinico-pathologic features, treatment and outcomes of breast cancer during pregnancy or the post-partum period

The Impact of Radiotherapy Delay in Breast Conservation Patients Not Receiving Chemotherapy and the Rationale for Dichotomizing the Radiation Oncology Time-Dependent Standard into Two Quality Measures

Timed Sequential Treatment With Cyclophosphamide, Doxorubicin, and an Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor–Secreting Breast Tumor Vaccine: A Chemotherapy Dose-Ranging Factorial Study of Safety and Immune Activation

Novel Biomarkers in the Continuum of Breast Cancer

Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update

High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer

Exploring the links of skeletal muscle mitochondrial oxidative capacity, physical functionality, and mental well-being of cancer survivors

ASO Visual Abstract: The Impact of Radiotherapy Delay in Breast-Conservation Patients Not Receiving Chemotherapy and the Rationale for Dichotomizing the Radiation Oncology Time-Dependent Standard into Two Quality Measures

Reply to H. Brauch et al

Suchergebnisse filtern